As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies. In work published ...
Feb 5, 2024
0
0
The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine. Researchers from the Perelman School of Medicine ...
Jan 25, 2024
0
8
The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary cancer.
Jan 24, 2024
0
6
In a country of suburban sprawl and endless highways, most Americans need a car in order to complete such basic tasks as going to work, getting groceries, and seeing the doctor. Those without cars are at the mercy of uneven ...
Jan 22, 2024
0
0
In the exploration of cancer treatment modalities, an article published in Biomolecules and Biomedicine titled "CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar," offers an examination ...
Jan 17, 2024
0
1
Researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital have developed a chimeric antigen receptor (CAR) T-cell therapy targeting T-cell ...
Jan 4, 2024
0
0
At EPFL's School of Engineering, Professor Li Tang's Laboratory of Biomaterials for Immunoengineering has made significant strides in cancer treatment research. In laboratory settings, this innovative CAR-T therapy has consistently ...
Jan 4, 2024
0
19
Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes, finds a recent study.
Dec 19, 2023
0
1
A Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflammation and Tissue Protection Institute (NEITPI) says his lab has employed a novel gene editing technology that might make personalized ...
Dec 13, 2023
0
1
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities.
Dec 11, 2023
0
10
